(4-bromomethylphenyl)acetic acid benzyl ester | 140233-65-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (4-bromomethylphenyl)acetic acid benzyl ester
• 英文别名: Benzyl 2-(4-(bromomethyl)phenyl)acetate；benzyl 2-[4-(bromomethyl)phenyl]acetate
• CAS: 140233-65-4
• 化学式: C₁₆H₁₅BrO₂
• 分子量: 319.198
• InChiKey: NULZSYVCOGJFJP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  19
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.19
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  (4-bromomethylphenyl)acetic acid benzyl ester 在 palladium on activated charcoal sodium azide 、 氢气 作用下， 以 甲醇 、 N,N-二甲基甲酰胺 为溶剂， 25.0 ℃ 、101.33 kPa 条件下， 生成 N-叔丁氧羰基-(4-氨基甲基苯基)乙酸
  参考文献：
  名称：

  Potent Dipeptide Inhibitors of the pp60^c-src SH2 Domain

  摘要：

  The design, synthesis, and evaluation of dipeptide analogues as ligands for the pp60(c-src) SH2 domain are described. The critical binding interactions between Ac-Tyr-Glu-N(n-C5H11)(2) (2) and the protein are established and form the basis for our structure-based drug design efforts. The effects of changes in both the C-terminal (11-27) and N-terminal (51-69) portions of the dipeptide are explored. Analogues with reduced overall charge (92-95) are also investigated. We demonstrate the feasibility of pairing structurally diverse subunits in a modest dipeptide framework with the goal of increasing the druglike attributes without sacrificing binding affinity.

  DOI：

  10.1021/jm970853a
• 作为产物：
  描述：

  4-(溴甲基)苯乙酸 在 吡啶 、 4-二甲氨基吡啶 、 氯化亚砜 、 三乙胺 作用下， 以 二氯甲烷 、 N,N-二甲基甲酰胺 、 甲苯 为溶剂， 反应 0.08h， 生成 (4-bromomethylphenyl)acetic acid benzyl ester
  参考文献：
  名称：

  Potent Dipeptide Inhibitors of the pp60^c-src SH2 Domain

  摘要：

  The design, synthesis, and evaluation of dipeptide analogues as ligands for the pp60(c-src) SH2 domain are described. The critical binding interactions between Ac-Tyr-Glu-N(n-C5H11)(2) (2) and the protein are established and form the basis for our structure-based drug design efforts. The effects of changes in both the C-terminal (11-27) and N-terminal (51-69) portions of the dipeptide are explored. Analogues with reduced overall charge (92-95) are also investigated. We demonstrate the feasibility of pairing structurally diverse subunits in a modest dipeptide framework with the goal of increasing the druglike attributes without sacrificing binding affinity.

  DOI：

  10.1021/jm970853a

文献信息

• Synthesis of aryl(difluoromethylenephosphonates) via electrophilic fluorination of α-carbanions of benzylic phosphonates with N-fluorobenzenesulfonimide
  作者：Scott D. Taylor、Christopher C. Kotoris、A.Nicole Dinaut、Mei-Jin Chen

  DOI：10.1016/s0040-4020(97)10395-7

  日期：1998.2

  The electrophilic fluorination of a wide variety of benzylic phosphonates with N-fluorobenzenesulfonimide has been examined. The fluorination reaction proceeds well in the presence of an array of functional groups such as nitro, bromo, ketone, ester, phenyl and ether groups. Phenyl and biphenyl derivatives containing two α,α-difluoromethylenephosphonate groups can also be prepared. This procedure is

  已经研究了多种苄基膦酸酯与N-氟苯磺酰亚胺的亲电子氟化。在一系列官能团如硝基，溴，酮，酯，苯基和醚基的存在下，氟化反应进行得很好。也可以制备含有两个α，α-二氟亚甲基膦酸酯基的苯基和联苯衍生物。该方法与甲基或乙基膦酸酯相容，但是与叔丁基酯或在对位处含有另外的苄基部分的苄基膦酸酯不相容。
• Ptp1b inhibitors and ligands
  申请人：——

  公开号：US20040191926A1

  公开（公告）日：2004-09-30

  Methods for discovery of enzyme ligands and inhibitors are disclosed. The methods comprise the creation and testing of combinatorial libraries comprising an active site-targeted component, a linker component and a peripheral site-targeted component. The methods also comprise a novel assay for determining whether a compound is a ligand of an enzyme. The assay evaluates whether the compound can inhibit the binding of a known ligand of the active site of the enzyme to a mutant of the enzyme that can bind the enzyme substrate but cannot catalyze an enzymatic reaction with the substrate. Various ligands and inhibitors of protein tyrosine phosphatase 1B (PTP1B) are also disclosed. These ligands and inhibitors were discovered using the above methods. One particular inhibitor discovered using the invention methods has the highest specificity and affinity of any PTP1B inhibitor discovered to date.

  本发明公开了一种发现酶配体和抑制剂的方法。该方法包括创建和测试组合库，其中包括一个活性位点定向组分、一个连接组分和一个周边位点定向组分。该方法还包括一种新的测定化合物是否为酶配体的测定方法。该测定方法评估化合物能否抑制已知酶活性位点的配体与能够结合酶底物但不能催化底物酶反应的酶突变体的结合。本发明还公开了多种蛋白酪氨酸磷酸酶1B（PTP1B）的配体和抑制剂。这些配体和抑制剂是使用上述方法发现的。使用本发明方法发现的一种特定抑制剂具有迄今为止任何PTP1B抑制剂中最高的特异性和亲和力。
• EP1435989A4
  申请人：——

  公开号：EP1435989A4

  公开（公告）日：2006-05-03
• PTP1B INHIBITORS AND LIGANDS
  申请人：ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY

  公开号：EP1435989A1

  公开（公告）日：2004-07-14
• BIARYLOXYMETHYLARENE-CARBOXYLIC ACIDS
  申请人：F. HOFFMANN-LA ROCHE AG

  公开号：EP1663936B1

  公开（公告）日：2008-01-09